Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene
Author:
Providence Kirwin M.1, White Lisa A.1, Tang Jianzhong1, Gonclaves John2, Staiano-Coico Lisa2, Higgins Paul J.1
Affiliation:
1. Center for Cell Biology & Cancer Research, Albany Medical College, Albany,NY 12208, USA 2. Department of Surgery, Weill Medical College of Cornell University, New York,NY 10021, USA
Abstract
Several proteases and their co-expressed inhibitors modulate the interdependent processes of cell migration and matrix proteolysis during wound repair. Transcription of the gene encoding plasminogen activator inhibitor type 1 (PAI-1), a serine protease inhibitor important in the control of barrier proteolysis and cell-to-matrix adhesion, is spatially-temporally regulated following epithelial denudation injury in vitro as well as in vivo. Using a well-defined culture model of acute epidermal wounding and reepithelialization, PAI-1 mRNA/protein synthesis was induced early after monolayer scraping and restricted to cells comprising the motile cohort. PAI-1 levels in locomoting cells remained elevated (relative to the distal,contact-inhibited monolayer regions) throughout the time course of trauma repair. Targeted PAI-1 downregulation by transfection of antisense PAI-1 expression constructs significantly impaired keratinocyte migration and monolayer scrape wound closure. Injury-induced PAI-1 transcription closely paralleled growth state-dependent controls on the PAI-1 gene. An E-box motif(CACGTG) in the PAI-1 proximal promoter (located at nucleotides -160 to -165),previously shown to be necessary for serum-induced PAI-1 expression, was bound by nuclear factors from wound-stimulated but not quiescent, contact-inhibited,keratinocytes. UV crosslinking approaches to identify E-box-binding factors coupled with deoxyoligonucleotide affinity chromatography and gel retardation assays confirmed at least one major E-box-binding protein in both serum- and wound-activated cells to be USF-1, a member of the helix-loop-helix family of transcription factors. An intact hexanucleotide E-box motif was necessary and sufficient for USF-1 binding using nuclear extracts from both serum- and wound-simulated cells. Two species of immunoreactive USF-1 were identified by western blotting of total cellular lysates that corresponded to the previously characterized phosphorylated and non-phosphorylated forms of the protein. USF-1 isolated by PAI-1 promoter-DNA affinity chromatography was almost exclusively phosphorylated. Only a fraction of the total cellular USF-1 in proliferating cultures, by comparison, was phosphorylated at any given time. PAI-1 E-box binding activity, assessed by probe mobility shift criteria,increased within 2 hours of monolayer scrape injury, a time frame consistent with wound-stimulated increases in PAI-1 transcription. Relative to intact cultures, scrape site-juxtaposed cells had significantly greater cytoplasmic and nuclear USF-1 immunoreactivity correlating with the specific in situ-restricted expression of PAI-1 transcripts/protein in the wound-edge cohort. USF-1 immunocytochemical staining declined significantly with increasing distance from the denudation site. These data are the first to indicate that binding of USF-1 to its target motif can be induced by `tissue'injury in vitro and implicate USF-1 as a transcriptional regulator of genes(e.g. PAI-1) involved in wound repair.
Publisher
The Company of Biologists
Reference83 articles.
1. Akiyoshi, S., Ishii, M., Nemoto, N., Kawabata, M., Aburatani, H. and Miyazano, K. (2001). Targets of transcriptional regulation by transforming growth factor-β: Expression profile analysis using oligonucleotide arrays. Jpn. J. Cancer Res.92, 252-268. 2. Andreasen, P. A., Kjoller, L., Christensen, L. and Duffy, M. J. (1997). The urokinase-type plasminogen activator systen in cancer metastasis: a review. Int. J. Cancer72, 1-22. 3. Bajou, K., Noel, A., Gerard, R. D., Masson, V., Brunner, N.,Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D. and Foidart, J. M. (1998). Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med.4, 923-928. 4. Bajou, K., Masson, V., Gerard, R. D., Schmitt, P. M., Albert,V., Praus, M., Lund, L. R., Frandsen, T. L., Brunner, N., Dano, K. et al.(2001). The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic stratagies. J. Cell Biol.152, 777-784. 5. Boehm, J. R., Kutz, S. M., Sage, E. H., Staiano-Coico, L. and Higgins, P. J. (1999). Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-β1. J. Cell. Physiol.181, 96-106.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|